Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 4/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.44 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.44 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.44 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | GRM5 | P41594 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31236475 | 1.00 | MEN1 (0.51) | MEN1KMT2AFAAHCNR2CES2 | |
| SCHEMBL1041440 | 0.85 | KMT2A (0.41) | MEN1KMT2AFAAHCNR2CES2 | |
| SCHEMBL7599431 | 0.85 | EPHX2 (0.48) | MEN1KMT2AFAAHCNR2NPC1 | |
| SCHEMBL7598473 | 0.84 | KDM4E (0.46) | CNR2NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL9179949 | 0.84 | KMT2A (0.43) | MEN1KMT2AFAAHCNR2CES2 | |
| SCHEMBL8058782 | 0.84 | FAAH (0.43) | MEN1KMT2AFAAHCNR2NPC1 | |
| SCHEMBL734321 | 0.84 | FAAH (0.43) | MEN1KMT2AFAAHCNR2NPC1 | |
| SCHEMBL14184724 | 0.84 | MEN1 (0.49) | MEN1KMT2AFAAHCNR2CES2 | |
| SCHEMBL25519094 | 0.84 | RAB9A (0.40) | MEN1KMT2AFAAHNPC1RAB9A | |
| SCHEMBL9616774 | 0.83 | KMT2A (0.42) | MEN1KMT2AFAAHCNR2CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10031142-B2 | In situ chemiluminescent substrates and assays | Life Technologies Corporation (US) | 2018-07-24 | — | — | US | disclosed |
| US-20070112061-A1 | Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound | MANAC INC. (JP) | 2007-05-17 | — | — | US | disclosed |
| US-20070112061-A1 | Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound | MANAC INC. (JP) | 2007-05-17 | — | — | US | disclosed |
| US-6417380-B1 | POLYCYCLOALKYL KETONE CONTAINING FLUORESCENT CHROMOPHORE IS ALKYLATED TO POLYCYCLOALKYLIDENE ETHER IN PRESENCE OF ALKALI METAL ALKOXIDE IN POLAR APROTIC SOLVENT | APPLIED BIOSYSTEMS, LLC | 2002-07-09 | — | — | US | disclosed |
| US-6124478-A | Methods of using 1,2-dioxetanes and kits therefore | TROPIX, INC. (US) | 2000-09-26 | — | — | US | disclosed |
| EP-0582317-B1 | Synthesis of 1,2-dioxetanes and intermediates therefor | TROPIX INC (US) | 1999-08-25 | — | — | EP | disclosed |
| US-5856522-A | Method of using synthesis of 1,2-dioxetanes and kits therefore | TROPIX, INC. (US) | 1999-01-05 | — | — | US | disclosed |
| US-5777133-A | Synthesis of 1, 2-dioxetanes and intermediates therefor | TROPIX, INC. (US) | 1998-07-07 | — | — | US | disclosed |
| US-5763681-A | ALPHA-2-ADAMANTYLIDENE-ALPHA-METHOXY-META-METHOXYTOLUENE AND RELATED COMPOUNDS AS INTERMEDIATES | TROPIX, INC. (US) | 1998-06-09 | — | — | US | disclosed |
| US-5679802-A | 1,2-dioxetanes useful in chemiluminescent immunoassays | TROPIX, INC. (US) | 1997-10-21 | — | — | US | disclosed |
| US-5637747-A | Synthesis of 1,2-dioxetanes and intermediates therefor | TROPIX, INC. (US) | 1997-06-10 | — | — | US | disclosed |
| EP-0368946-B1 | 1,2-DIOXETANES | TROPIX INC (US) | 1994-09-14 | — | — | EP | disclosed |
| EP-0582317-A2 | Synthesis of 1,2-dioxetanes and intermediates therefor | TROPIX, INC. (US) | 1994-02-09 | — | — | EP | disclosed |
| US-5225584-A | Phosphonate esters and trialkylsilyl phosphonate esters | TROPIX, INC. (US) | 1993-07-06 | — | — | US | disclosed |
| US-5177241-A | SYNTHESIS OF 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | APPLIED BIOSYSTEMS, LLC | 1993-01-05 | — | — | US | disclosed |
| WO-1991003479-A1 | SYNTHESIS OF STABLE, WATER-SOLUBLE CHEMILUMINESCENT 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | TROPIX, INC. (US) | 1991-03-21 | — | — | WO | disclosed |
| US-4956477-A | Synthesis of 1,2-dioxetanes | TROPIX, INC. (US) | 1990-09-11 | — | — | US | disclosed |
| EP-0368946-A1 | 1,2-DIOXETANES. | QUEST SYSTEMS INC (US) | 1990-05-23 | — | — | EP | disclosed |
| EP-0368946-A4 | 1,2-DIOXETANES. | QUEST SYSTEMS INC (US) | 1990-05-14 | — | — | EP | disclosed |
| WO-1989006226-A1 | SYNTHESIS OF 1,2-DIOXETANES AND INTERMEDIATES THEREFOR | QUEST SYSTEMS, INC. (US) | 1989-07-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112061-A1 | Heat- or singlet oxygen-generating agents and cancer treatment compositions comprising organic peroxide or chemiluminescent compound | HSPE1, MCL1, HMOX1 | MEN1 513/4885KMT2A 1888/4885FAAH 3387/4885 |
| US-10031142-B2 | In situ chemiluminescent substrates and assays | DNASE1L3, DCLRE1B, RNASE1 | MEN1 2991/4885KMT2A 4351/4885FAAH 2224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.